Boehringer Ingelheim and Veeva Collaborate for Advancing Clinical and Regulatory Operations in Animal Health
Shots:
- Veeva Systems and Boehringer Ingelheim have partnered to utilize Veeva Vault Clinical & Veeva Vault RIM technologies to streamline the clinical & regulatory operations and accelerate the development of new medicines for animals
- Boehringer Ingelheim’s animal health unit will leverage Veeva Vault CTMS for study management and monitoring while Veeva Vault eTMF for real-time inspection readiness, visibility & control
- Vault RIM applications like Veeva Vault Registrations, Veeva Vault Submissions, and Veeva Vault Submissions Archive will be utilized for advancing regulatory operations. Integrating these technologies on a single cloud platform will allow real-time access and easy information exchange
Ref: PR Newswire | Image: Boehringer Ingelheim
Related News:- Boehringer Ingelheim Collaborated with Riboure Pharmaceuticals to Develop RNAi Based Therapies for the Treatment of Liver Diseases
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
